Cocoon Biotech, Inc.
Boston, US · Founded 2013 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
AT
Ailis Tweed-KentExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$385.2KraisedDec 2021 · 6 investors · BiotechnologyRule 506(b)
▶$385.2KraisedDec 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles KoppelDirector
- Mary ThistleDirector
- Annalisa JenkinsDirector
- Ailis Tweed-KentExecutive Officer, Director
- Offering amount
- $1000K
- Amount sold
- $385.2K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$865.4KraisedOct 2020 · 4 investors · BiotechnologyRule 506(b)
▶$865.4KraisedOct 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mary ThistleDirector
- Annalisa JenkinsDirector
- Ailis Tweed-KentExecutive Officer, Director
- Offering amount
- $865.4K
- Amount sold
- $865.4K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedNov 2019 · 32 investors · BiotechnologyRule 506(b)
▶$4.5MraisedNov 2019 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Grace ColonDirector
- Ailis Tweed-KentExecutive Officer, Director
- Mary ThistleDirector
- Annalisa JenkinsDirector
- Amount sold
- $4.5M
- Minimum investment
- $5K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedOct 2015 · 18 investors · BiotechnologyRule 506(b)
▶$1.8MraisedOct 2015 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ailis Tweed-KentExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.8M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.